What are the difficulties in translating biological data on neuroprotection from animals to human ICH patients?
The difficulties in translating biological data on neuroprotection from animals to human ICH patients include identifying the correct animal model system and a clinically relevant time frame for treatment. Additionally, there may be difficulty in accurately predicting the efficacy of treatments and whether a particular treatment will be safe and effective for human ICH patients.